Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00018668
What this trial is testing

Antipsychotic Response in Schizophrenia

Who this might be right for
Schizophrenia
US Department of Veterans Affairs
Not applicableStudy completedNCT03522168
What this trial is testing

Long-term Antipsychotic Pediatric Safety Trial

Who this might be right for
Weight, Body
Duke University 509
Testing effectiveness (Phase 2)UnknownNCT01845259
What this trial is testing

Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?

Who this might be right for
Impaired Glucose Tolerance Associated With Drugs
Psychiatric Centre Rigshospitalet 103
Large-scale testing (Phase 3)Study completedNCT01714713
What this trial is testing

A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

Who this might be right for
SchizophreniaImpaired Cognition
FORUM Pharmaceuticals Inc 830
Testing effectiveness (Phase 2)UnknownNCT00604760
What this trial is testing

Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Cognitive Impairment Associated With Schizophrenia
Memory Pharmaceuticals 160
Not applicableLooking for participantsNCT07025590
What this trial is testing

Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)

Who this might be right for
Cardiovascular Diseases (CVD)Depression Anxiety Disorder
Guangdong Provincial People's Hospital 106
Large-scale testing (Phase 3)Ended earlyNCT00287742
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Janssen Pharmaceutical K.K. 33
Not applicableStudy completedNCT02374996
What this trial is testing

Pharmacoepigenetics of Bipolar Disorder Treatment

Who this might be right for
Antipsychotic AgentsBipolar Disorder
Wayne State University 40
Large-scale testing (Phase 3)Looking for participantsNCT07184619
What this trial is testing

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

Who this might be right for
Treatment-resistant Schizophrenia
Newron Pharmaceuticals SPA 400
Post-approval studies (Phase 4)Study completedNCT00290121
What this trial is testing

Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics

Who this might be right for
Schizophrenia
Université de Montréal 25
Not applicableStudy completedNCT00552500
What this trial is testing

Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia

Who this might be right for
Insulin ResistanceBody Composition
Washington University School of Medicine 120
Post-approval studies (Phase 4)Study completedNCT01811160
What this trial is testing

Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

Who this might be right for
Second Generation Antipsychotic Induced Metabolic Adverse Effects
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente 50
Early research (Phase 1)Study completedNCT05402111
What this trial is testing

A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 31
Post-approval studies (Phase 4)Study completedNCT03376763
What this trial is testing

MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics

Who this might be right for
SchizophreniaAntipsychoticsLong-Acting Injection+2 more
Korea Otsuka Pharmaceutical Co., Ltd. 201
Early research (Phase 1)Study completedNCT01871987
What this trial is testing

Study to Evaluate the Effect of Food Intake on the Plasma Concentration Changes of Quetiapine After Oral Administration of FK949E in Healthy Volunteers

Who this might be right for
HealthyPlasma Concentration Change of Quetiapine
Astellas Pharma Inc 24
Post-approval studies (Phase 4)Study completedNCT00330551
What this trial is testing

Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia

Who this might be right for
Schizophrenia
University of California, Los Angeles 126
Testing effectiveness (Phase 2)Study completedNCT04461119
What this trial is testing

Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

Who this might be right for
Schizophrenia
Newron Pharmaceuticals SPA 138
Not applicableStudy completedNCT00845572
What this trial is testing

The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center

Who this might be right for
SchizophreniaSchizoaffective
The University of Texas Health Science Center at San Antonio 30
Post-approval studies (Phase 4)Study completedNCT00246259
What this trial is testing

A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
Janssen-Ortho Inc., Canada 77
Not applicableUnknownNCT02093858
What this trial is testing

The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic Syndrome

Who this might be right for
SchizophreniaMetabolic Syndrome
Central South University 212
Next Page